These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Acyclovir and herpesvirus infections. A review of the literature. Pallasch TJ; Joseph CE; Gill CJ Oral Surg Oral Med Oral Pathol; 1984 Jan; 57(1):41-4. PubMed ID: 6320078 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of oral acyclovir therapy. Fletcher C; Bean B Drug Intell Clin Pharm; 1985; 19(7-8):518-24. PubMed ID: 2992899 [TBL] [Abstract][Full Text] [Related]
4. Drugs five years later: acyclovir. Dorsky DI; Crumpacker CS Ann Intern Med; 1987 Dec; 107(6):859-74. PubMed ID: 3318610 [TBL] [Abstract][Full Text] [Related]
5. Valaciclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in herpesvirus infections. Perry CM; Faulds D Drugs; 1996 Nov; 52(5):754-72. PubMed ID: 9118821 [TBL] [Abstract][Full Text] [Related]
6. Acyclovir. A review of its pharmacodynamic properties and therapeutic efficacy. Richards DM; Carmine AA; Brogden RN; Heel RC; Speight TM; Avery GS Drugs; 1983 Nov; 26(5):378-438. PubMed ID: 6315332 [TBL] [Abstract][Full Text] [Related]
8. Update on acyclovir: oral therapy for herpesvirus infections. True BL; Carter BL Clin Pharm; 1984; 3(6):607-13. PubMed ID: 6096075 [TBL] [Abstract][Full Text] [Related]
9. Acyclovir - a review of the preclinical and early clinical data of a new antiherpes drug. Brigden D; Fiddian P; Rosling AE; Ravenscroft T Antiviral Res; 1981 Nov; 1(4):203-12. PubMed ID: 6280605 [TBL] [Abstract][Full Text] [Related]
10. Antiherpes drugs: promises and pitfalls. de Clercq E Eur J Clin Microbiol; 1984 Apr; 3(2):96-107. PubMed ID: 6327297 [TBL] [Abstract][Full Text] [Related]
11. Acyclovir and other chemotherapy for herpes group viral infections. Balfour HH Annu Rev Med; 1984; 35():279-91. PubMed ID: 6326661 [TBL] [Abstract][Full Text] [Related]
12. Acyclovir for intravenous use. Committee on Infectious Diseases and Immunization, Canadian Paediatric Society. Can Med Assoc J; 1984 Nov; 131(9):1045-6. PubMed ID: 6093977 [No Abstract] [Full Text] [Related]
13. The present and future for acyclovir. Brigden D; Keeney RE; King DH J Antimicrob Chemother; 1983 Sep; 12 Suppl B():195-9. PubMed ID: 6313599 [No Abstract] [Full Text] [Related]
14. The acyclovir legacy: its contribution to antiviral drug discovery. Darby G J Med Virol; 1993; Suppl 1():134-8. PubMed ID: 8245880 [TBL] [Abstract][Full Text] [Related]
15. Acyclovir: the past ten years. Whitley RJ; Middlebrooks M; Gnann JW Adv Exp Med Biol; 1990; 278():243-53. PubMed ID: 1963040 [No Abstract] [Full Text] [Related]
16. Acyclovir: an update of the clinical applications of this antiherpes agent. Fiddian AP; Brigden D; Yeo JM; Hickmott EA Antiviral Res; 1984 Jun; 4(3):99-117. PubMed ID: 6089659 [TBL] [Abstract][Full Text] [Related]
17. Intravenous acyclovir for herpesvirus in immunocompromised patients. Dan M; Michaeli D; Siegman-Igra Y Isr J Med Sci; 1985 Jan; 21(1):27-31. PubMed ID: 2982763 [TBL] [Abstract][Full Text] [Related]
18. Acyclovir: evaluation of a new antiviral agent. Rosenberry KR; Bryan CK; Sohn CA Clin Pharm; 1982; 1(5):399-406. PubMed ID: 6307582 [No Abstract] [Full Text] [Related]
19. Acyclovir in the treatment of infection due to herpes viruses. Zicha J; Stafová J; Vacek V Czech Med; 1986; 9(4):203-5. PubMed ID: 3028734 [TBL] [Abstract][Full Text] [Related]
20. Acyclovir prophylaxis against herpes virus infections in severely immunocompromised patients: randomised double blind trial. Hann IM; Prentice HG; Blacklock HA; Ross MG; Brigden D; Rosling AE; Burke C; Crawford DH; Brumfitt W; Hoffbrand AV Br Med J (Clin Res Ed); 1983 Aug; 287(6389):384-8. PubMed ID: 6307464 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]